Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jürgen C. Schmidt is active.

Publication


Featured researches published by Jürgen C. Schmidt.


The Lancet | 2015

Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

John N Newton; Adam D M Briggs; Christopher J L Murray; Daniel Dicker; Kyle Foreman; Haidong Wang; Mohsen Naghavi; Mohammad H. Forouzanfar; Summer Lockett Ohno; Ryan M. Barber; Theo Vos; Jeffrey D. Stanaway; Jürgen C. Schmidt; Andrew Hughes; Derek F J Fay; R. Ecob; C. Gresser; Martin McKee; Harry Rutter; I. Abubakar; R. Ali; H R Anderson; Amitava Banerjee; Derrick Bennett; Eduardo Bernabé; Kamaldeep Bhui; Stan Biryukov; Rupert Bourne; Carol Brayne; Nigel Bruce

Summary Background In the Global Burden of Disease Study 2013 (GBD 2013), knowledge about health and its determinants has been integrated into a comparable framework to inform health policy. Outputs of this analysis are relevant to current policy questions in England and elsewhere, particularly on health inequalities. We use GBD 2013 data on mortality and causes of death, and disease and injury incidence and prevalence to analyse the burden of disease and injury in England as a whole, in English regions, and within each English region by deprivation quintile. We also assess disease and injury burden in England attributable to potentially preventable risk factors. England and the English regions are compared with the remaining constituent countries of the UK and with comparable countries in the European Union (EU) and beyond. Methods We extracted data from the GBD 2013 to compare mortality, causes of death, years of life lost (YLLs), years lived with a disability (YLDs), and disability-adjusted life-years (DALYs) in England, the UK, and 18 other countries (the first 15 EU members [apart from the UK] and Australia, Canada, Norway, and the USA [EU15+]). We extended elements of the analysis to English regions, and subregional areas defined by deprivation quintile (deprivation areas). We used data split by the nine English regions (corresponding to the European boundaries of the Nomenclature for Territorial Statistics level 1 [NUTS 1] regions), and by quintile groups within each English region according to deprivation, thereby making 45 regional deprivation areas. Deprivation quintiles were defined by area of residence ranked at national level by Index of Multiple Deprivation score, 2010. Burden due to various risk factors is described for England using new GBD methodology to estimate independent and overlapping attributable risk for five tiers of behavioural, metabolic, and environmental risk factors. We present results for 306 causes and 2337 sequelae, and 79 risks or risk clusters. Findings Between 1990 and 2013, life expectancy from birth in England increased by 5·4 years (95% uncertainty interval 5·0–5·8) from 75·9 years (75·9–76·0) to 81·3 years (80·9–81·7); gains were greater for men than for women. Rates of age-standardised YLLs reduced by 41·1% (38·3–43·6), whereas DALYs were reduced by 23·8% (20·9–27·1), and YLDs by 1·4% (0·1–2·8). For these measures, England ranked better than the UK and the EU15+ means. Between 1990 and 2013, the range in life expectancy among 45 regional deprivation areas remained 8·2 years for men and decreased from 7·2 years in 1990 to 6·9 years in 2013 for women. In 2013, the leading cause of YLLs was ischaemic heart disease, and the leading cause of DALYs was low back and neck pain. Known risk factors accounted for 39·6% (37·7–41·7) of DALYs; leading behavioural risk factors were suboptimal diet (10·8% [9·1–12·7]) and tobacco (10·7% [9·4–12·0]). Interpretation Health in England is improving although substantial opportunities exist for further reductions in the burden of preventable disease. The gap in mortality rates between men and women has reduced, but marked health inequalities between the least deprived and most deprived areas remain. Declines in mortality have not been matched by similar declines in morbidity, resulting in people living longer with diseases. Health policies must therefore address the causes of ill health as well as those of premature mortality. Systematic action locally and nationally is needed to reduce risk exposures, support healthy behaviours, alleviate the severity of chronic disabling disorders, and mitigate the effects of socioeconomic deprivation. Funding Bill & Melinda Gates Foundation and Public Health England.


Archive | 2015

Changes in health in England with analysis by English region and areas of deprivation: findings of the Global Burden of Disease Study 2013

John N Newton; Adam D M Briggs; Christopher J. L. Murray; Daniel Dicker; Kyle Foreman; Haidong Wang; Mohsen Naghavi; Mohammad H. Forouzanfar; Summer Lockett Ohno; Ryan M. Barber; Theo Vos; Jeffrey D. Stanaway; Jürgen C. Schmidt; Andrew J. Hughes; Derek F J Fay; Russell Ecob; Charis Gresser; Martin McKee; Harry Rutter; Ibrahim Abubakar; Raghib Ali; H. Ross Anderson; Amitava Banerjee; Derrick Bennett; Eduardo Bernabé; Kamaldeep Bhui; Stanley M Biryukov; Rupert Bourne; Carol Brayne; Nigel Bruce

Summary Background In the Global Burden of Disease Study 2013 (GBD 2013), knowledge about health and its determinants has been integrated into a comparable framework to inform health policy. Outputs of this analysis are relevant to current policy questions in England and elsewhere, particularly on health inequalities. We use GBD 2013 data on mortality and causes of death, and disease and injury incidence and prevalence to analyse the burden of disease and injury in England as a whole, in English regions, and within each English region by deprivation quintile. We also assess disease and injury burden in England attributable to potentially preventable risk factors. England and the English regions are compared with the remaining constituent countries of the UK and with comparable countries in the European Union (EU) and beyond. Methods We extracted data from the GBD 2013 to compare mortality, causes of death, years of life lost (YLLs), years lived with a disability (YLDs), and disability-adjusted life-years (DALYs) in England, the UK, and 18 other countries (the first 15 EU members [apart from the UK] and Australia, Canada, Norway, and the USA [EU15+]). We extended elements of the analysis to English regions, and subregional areas defined by deprivation quintile (deprivation areas). We used data split by the nine English regions (corresponding to the European boundaries of the Nomenclature for Territorial Statistics level 1 [NUTS 1] regions), and by quintile groups within each English region according to deprivation, thereby making 45 regional deprivation areas. Deprivation quintiles were defined by area of residence ranked at national level by Index of Multiple Deprivation score, 2010. Burden due to various risk factors is described for England using new GBD methodology to estimate independent and overlapping attributable risk for five tiers of behavioural, metabolic, and environmental risk factors. We present results for 306 causes and 2337 sequelae, and 79 risks or risk clusters. Findings Between 1990 and 2013, life expectancy from birth in England increased by 5·4 years (95% uncertainty interval 5·0–5·8) from 75·9 years (75·9–76·0) to 81·3 years (80·9–81·7); gains were greater for men than for women. Rates of age-standardised YLLs reduced by 41·1% (38·3–43·6), whereas DALYs were reduced by 23·8% (20·9–27·1), and YLDs by 1·4% (0·1–2·8). For these measures, England ranked better than the UK and the EU15+ means. Between 1990 and 2013, the range in life expectancy among 45 regional deprivation areas remained 8·2 years for men and decreased from 7·2 years in 1990 to 6·9 years in 2013 for women. In 2013, the leading cause of YLLs was ischaemic heart disease, and the leading cause of DALYs was low back and neck pain. Known risk factors accounted for 39·6% (37·7–41·7) of DALYs; leading behavioural risk factors were suboptimal diet (10·8% [9·1–12·7]) and tobacco (10·7% [9·4–12·0]). Interpretation Health in England is improving although substantial opportunities exist for further reductions in the burden of preventable disease. The gap in mortality rates between men and women has reduced, but marked health inequalities between the least deprived and most deprived areas remain. Declines in mortality have not been matched by similar declines in morbidity, resulting in people living longer with diseases. Health policies must therefore address the causes of ill health as well as those of premature mortality. Systematic action locally and nationally is needed to reduce risk exposures, support healthy behaviours, alleviate the severity of chronic disabling disorders, and mitigate the effects of socioeconomic deprivation. Funding Bill & Melinda Gates Foundation and Public Health England.


The Lancet | 2018

Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Nicholas Steel; John Ford; John N Newton; Adrian C J Davis; Theo Vos; Mohsen Naghavi; Scott D Glenn; Andrew Hughes; Alice M. Dalton; Diane Stockton; Ciaran Humphreys; Mary Anne T Dallat; Jürgen C. Schmidt; Julian Flowers; Sebastian Fox; Ibrahim Abubakar; Robert W Aldridge; Allan Baker; Carol Brayne; Traolach S. Brugha; Simon Capewell; Josip Car; C Cooper; Majid Ezzati; Justine Fitzpatrick; Felix Greaves; Roderick J. Hay; Simon I. Hay; Frank Kee; Heidi J. Larson

Summary Background Previous studies have reported national and regional Global Burden of Disease (GBD) estimates for the UK. Because of substantial variation in health within the UK, action to improve it requires comparable estimates of disease burden and risks at country and local levels. The slowdown in the rate of improvement in life expectancy requires further investigation. We use GBD 2016 data on mortality, causes of death, and disability to analyse the burden of disease in the countries of the UK and within local authorities in England by deprivation quintile. Methods We extracted data from the GBD 2016 to estimate years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and attributable risks from 1990 to 2016 for England, Scotland, Wales, Northern Ireland, the UK, and 150 English Upper-Tier Local Authorities. We estimated the burden of disease by cause of death, condition, year, and sex. We analysed the association between burden of disease and socioeconomic deprivation using the Index of Multiple Deprivation. We present results for all 264 GBD causes of death combined and the leading 20 specific causes, and all 84 GBD risks or risk clusters combined and 17 specific risks or risk clusters. Findings The leading causes of age-adjusted YLLs in all UK countries in 2016 were ischaemic heart disease, lung cancers, cerebrovascular disease, and chronic obstructive pulmonary disease. Age-standardised rates of YLLs for all causes varied by two times between local areas in England according to levels of socioeconomic deprivation (from 14 274 per 100 000 population [95% uncertainty interval 12 791–15 875] in Blackpool to 6888 [6145–7739] in Wokingham). Some Upper-Tier Local Authorities, particularly those in London, did better than expected for their level of deprivation. Allowing for differences in age structure, more deprived Upper-Tier Local Authorities had higher attributable YLLs for most major risk factors in the GBD. The population attributable fractions for all-cause YLLs for individual major risk factors varied across Upper-Tier Local Authorities. Life expectancy and YLLs have improved more slowly since 2010 in all UK countries compared with 1990–2010. In nine of 150 Upper-Tier Local Authorities, YLLs increased after 2010. For attributable YLLs, the rate of improvement slowed most substantially for cardiovascular disease and breast, colorectal, and lung cancers, and showed little change for Alzheimers disease and other dementias. Morbidity makes an increasing contribution to overall burden in the UK compared with mortality. The age-standardised UK DALY rate for low back and neck pain (1795 [1258–2356]) was higher than for ischaemic heart disease (1200 [1155–1246]) or lung cancer (660 [642–679]). The leading causes of ill health (measured through YLDs) in the UK in 2016 were low back and neck pain, skin and subcutaneous diseases, migraine, depressive disorders, and sense organ disease. Age-standardised YLD rates varied much less than equivalent YLL rates across the UK, which reflects the relative scarcity of local data on causes of ill health. Interpretation These estimates at local, regional, and national level will allow policy makers to match resources and priorities to levels of burden and risk factors. Improvement in YLLs and life expectancy slowed notably after 2010, particularly in cardiovascular disease and cancer, and targeted actions are needed if the rate of improvement is to recover. A targeted policy response is also required to address the increasing proportion of burden due to morbidity, such as musculoskeletal problems and depression. Improving the quality and completeness of available data on these causes is an essential component of this response. Funding Bill & Melinda Gates Foundation and Public Health England.


BMC Proceedings | 2016

Proceedings of the International Workshop ‘From Global Burden of Disease Studies to National Burden of Disease Surveillance'

Christa Scheidt-Nave; Thomas Ziese; Judith Fuchs; Dietrich Plass; Tom Achoki; Katherine Leach-Kemon; Peter Speyer; William E. Heisel; Emmanuela Gakidou; Theo Vos; Mohammad H. Forouzanfar; Jürgen C. Schmidt; Claudia Stein; Elena von der Lippe; Benjamin Barnes; Markus Busch; Nina Buttmann-Schweiger; Christin Heidemann; Klaus Kraywinkel; Enno Nowossadeck; Udo Buchholz; Matthias an der Heiden; Tim Eckmanns; Sebastian Haller; Myriam Tobollik; Dagmar Kallweit; Dirk Wintermeyer

Table of contentsI1 Introduction and aims of the workshop Christa Scheidt-Nave, Thomas Ziese, Judith Fuchs, Dietrich PlassS1 History, concept, and current results of GBD for GermanyTom Achoki, Katherine Leach-Kemon, Peter Speyer, William E. Heisel, Emmanuela Gakidou, Theo VosS2 Methodology of the GBD 2013 Study–Mortality, Morbidity, Risk-FactorsMohammad Hossein ForouzanfarS3 National burden of disease surveillance examples of good practice: the case of Public Health EnglandJürgen C. SchmidtS4 Critical aspects of the burden of disease methodology and country-specific challengesClaudia E. SteinS5 Non-communicable disease surveillance in Germany – public health and data challengesChrista Scheidt-Nave, Elena von der Lippe, Benjamin Barnes, Markus Busch, Nina Buttmann-Schweiger, Judith Fuchs, Christin Heidemann, Klaus Kraywinkel, Enno Nowossadeck, Thomas ZieseS6 Different approaches in estimating the burden of communicable diseases using the examples of the healthcare associated infections and influenzaUdo Buchholz, Matthias an der Heiden, Tim Eckmanns, Sebastian HallerS7 Behavioral and environmental attributable risk estimationMohammad Hossein ForouzanfarS8 Environmental Burden of Disease (EBD) in Germany – past achievements and future perspectivesDietrich Plass, Myriam Tobollik, Dagmar Kallweit, Dirk WintermeyerC1 Conclusions of the workshopChrista Scheidt-Nave, Thomas Ziese, Judith Fuchs, Dietrich Plass


The Lancet | 2016

Use of the Global Burden of Disease methodology to estimate disease burden of air pollution in England

Jürgen C. Schmidt; Andrew Hughes; Sebastian Fox

Abstract Background An analysis of data from the Global Burden of Disease (GBD) Study 2013 highlighted the role of air pollution and the concomitant lack of published data linking this risk with fatal and non-fatal outcomes. The GBD methodology improves comprehensively estimation of the health outcomes attributable to air pollution, broken down by geography and socioeconomic deprivation. The aim of our study was to assess the suitability of GBD model estimates to provide a comprehensive overview of air pollution. Methods The GBD methodology divides risk factors into three main categories—behavioural, metabolic, and environmental, the latter including air pollution. Data and methods from the GBD 2013 study were used to relate air pollution (annual average daily exposure to outdoor air concentrations of particulate matter) to the burden of disease, in particular disability-adjusted life-years (DALYs), in England between 1990 and 2013. The analysis distinguished between English regions, and between subregional areas divided into quintiles by the Index of Multiple Deprivation score. Findings Between 1990 and 2013, the rates of DALYs attributed to each of the three major risk categories have declined, as has the exposure to tobacco, high blood pressure, cholesterol, and air pollution. Among leading risk factors, air pollution has moved from rank nine in 1990 to rank 12 in 2013, responsible for 294 DALYs per 100 000 (age-standardised, both sexes). Environmental risks still cause 4·7% (648 099) of total DALYs. A substantial and consistent gap continues to exist between most and least deprived quintiles of the population, and most and least deprived regions. In 1990 the poorest people in North West England lost 1415·5 years of life compared with 656·4 lost by the richest people in South East England. The data for 2013 were 477·2 and 188·9, respectively. Interpretation The importance of air pollution as a risk factor in England has decreased over the past 20 years but remains quantitatively important. There is a consistent gap across time between regions and levels of deprivation. The GBD programme offers a comprehensive methodology to monitor evolution over time and across regions. Funding Public Health England.


Archive | 2015

Changes in health in England, with analysis by English regions and areas of deprivation, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 - Supplementary Information 1

John N Newton; Adam D M Briggs; Christopher J. L. Murray; Daniel Dicker; Kyle Foreman; Haidong Wang; Mohsen Naghavi; Mohammad H. Forouzanfar; S. Lockett Ohno; Ryan M. Barber; Theo Vos; Jeffrey D. Stanaway; Jürgen C. Schmidt; Andrew Hughes; Derek F J Fay; R. Ecob; C. Gresser; Martin McKee; Harry Rutter; Ibrahim Abubakar; Radwan Al Ali; HarryL Anderson; Amitava Banerjee; David A. Bennett; Eduardo Bernabé; Kamaldeep Bhui; Stan Biryukov; Rupert Bourne; Carol Brayne; Nigel Bruce

Collaboration


Dive into the Jürgen C. Schmidt's collaboration.

Top Co-Authors

Avatar

Theo Vos

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Carol Brayne

University of Cambridge

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mohsen Naghavi

University of Washington

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge